Delivery Order SPE2DR25D2104-SPE2DR26F3SVS
Award Date 1/5/26
Potential Completion Date 1/6/26
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $30,876.03 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick autoinjector pens on November 13, 2025, with an ultimate completion date of November 14, 2025. This competitive award utilizes firm fixed pricing and represents a single delivery transaction under a larger contract vehicle. REPATHA (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in eligible patients. The place of...
- The Defense Logistics Agency awarded a $18,738.83 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is the company's corporate headquarters in Conshohocken, Pennsylvania. REPATHA (evolocumab) is a PCSK9...
- The Defense Logistics Agency awarded a $5,473.29 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector units, with a completion date of December 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol, representing the type of specialized pharmaceutical product that...
- The Defense Logistics Agency awarded a $22,002.23 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. REPATHA (evolocumab) is a PCSK9 inhibitor used in cardiovascular disease...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,776.39 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of December 10, 2025. The contract utilized firm fixed pricing under a non-competitive delivery order, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a single delivery order executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $44,057.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside contract represents a competitive award to the prime contractor, which is headquartered in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $14,080.56 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, PA. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,243.03 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, performing out of the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,214.99 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency (DLA) awarded a $88,817.52 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of December 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a continuation order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where...